Mannose supplementation in PMM2-CDG

Mannose supplementation in PMM2-CDG

Abstract In this response to the letter by Witters et al., we refer to the authors' arguments regarding spontaneous enhancement of glycosylation and the claim, that mannose has no place in the treatment of PMM2-CDG. Our paper “Dietary mannose supplementation in phosphomannomutase 2 deficiency (...

Full description

Bibliographic Details
Main Authors:	Roman Taday, Julien H. Park, Marianne Grüneberg, Ingrid DuChesne, Janine Reunert, Thorsten Marquardt
Format:	Article
Language:	English
Published:	BMC 2021-08-01
Series:	Orphanet Journal of Rare Diseases
Subjects:	PMM2 Congenital disorder of glycosylation Mannose Galactose Therapy
Online Access:	https://doi.org/10.1186/s13023-021-01988-x

Similar Items

Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
by: Roman Taday, et al.
Published: (2020-09-01)

Unsuccessful intravenous D-mannose treatment in PMM2-CDG
by: Sarah C. Grünert, et al.
Published: (2019-10-01)

Congenital disorder of glycosilation PMM2-CDG
by: A. A. Kamalova, et al.
Published: (2019-11-01)

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial
by: Peter Witters, et al.
Published: (2021-03-01)

Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study
by: Peter Witters, et al.
Published: (2021-02-01)

Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
by: Peter Witters, et al.
Published: (2017-11-01)

Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin
by: C.A. González-Domínguez, et al.
Published: (2020-12-01)

PMM2‐CDG caused by uniparental disomy: Case report and literature review
by: Laurien Vaes, et al.
Published: (2020-07-01)

Fatal outcome after heart surgery in PMM2-CDG due to a rare homozygous gene variant with double effects
by: Marlen Görlacher, et al.
Published: (2020-12-01)

Stroke-Like Episodes in PMM2-CDG: When the Lack of Other Evidence Is the Only Evidence
by: Mercedes Serrano, et al.
Published: (2021-10-01)

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG
by: Sangeetha Iyer, et al.
Published: (2019-11-01)

CDG Therapies: From Bench to Bedside
by: Sandra Brasil, et al.
Published: (2018-04-01)

L-Fucose treatment of FUT8-CDG
by: Julien H. Park, et al.
Published: (2020-12-01)

An investigation of the vibrational spectra of glucose, galactose, and mannose.
by: Wells, Henry Alden, Jr.
Published: (2005)

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
by: Rita Francisco, et al.
Published: (2020-07-01)

Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway
by: Raquel López-Gálvez, et al.
Published: (2020-10-01)

Novel Splicing Variant in the PMM2 Gene in a Patient With PMM2-CDG Syndrome Presenting With Pericardial Effusion: A Case Report
by: Katerina Slaba, et al.
Published: (2020-10-01)

Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients
by: Hossein Moravej, et al.
Published: (2020-01-01)

Limitations of galactose therapy in phosphoglucomutase 1 deficiency
by: Kristine Nolting, et al.
Published: (2017-12-01)

Mannose phosphate isomerase deficiency‐congenital disorder of glycosylation (MPI‐CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia
by: Chris Mühlhausen, et al.
Published: (2020-09-01)

A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)
by: Natalia Lourdes Serrano, et al.
Published: (2017-09-01)

Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
by: Kinza Noman, et al.
Published: (2020-12-01)

Four New Cases of SLC35A2-CDG With Novel Mutations and Clinical Features
by: Kuerbanjiang Abuduxikuer, et al.
Published: (2021-05-01)

A mutation in mannose‐phosphate‐dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy
by: Walinka vanTol, et al.
Published: (2019-11-01)

β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
by: Maria Monticelli, et al.
Published: (2019-08-01)

The development of end stage renal disease in two patients with PMM2-CDG
by: Berry, G.T, et al.
Published: (2022)

Anesthetic management of a child with phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG)
by: Wataru Sakai, et al.
Published: (2017-02-01)

SLC37A4-CDG: Mislocalization of the glucose-6-phosphate transporter to the Golgi causes a new congenital disorder of glycosylation
by: Thorsten Marquardt, et al.
Published: (2020-12-01)

Stroke-Like Episodes and Cerebellar Syndrome in Phosphomannomutase Deficiency (PMM2-CDG): Evidence for Hypoglycosylation-Driven Channelopathy
by: Mercè Izquierdo-Serra, et al.
Published: (2018-02-01)

Conservation and expression patterns divergence of ascorbic acid D-mannose/L-galactose pathway genes in Brassica rapa
by: Weike eDuan, et al.
Published: (2016-06-01)

The Analysis of Variants in the General Population Reveals That PMM2 Is Extremely Tolerant to Missense Mutations and That Diagnosis of PMM2-CDG Can Benefit from the Identification of Modifiers
by: Valentina Citro, et al.
Published: (2018-07-01)

The Evidence of Non n-glycan Linked Mannose in Exochitinase 42kDa, from Trichoderma harzianum BIO10671 Glycosylation
by: Muskhazli, M., et al.
Published: (2006-01-01)

THE EVIDENCE OF NON N-GLYCAN LINKED MANNOSE IN EXOCHITINASE (42 kDa) FROM Trichoderma harzianum BIO10671 GLYCOSYLATION
by: Muskhazli Mustafa, et al.
Published: (2017-11-01)

Effects of headwinds on towing tank resistance and PMM tests for ONR Tumblehome
by: Cook, Shane Stuart
Published: (2011)

The Synthesis of Mannose-6-Phosphate Using Polyphosphate-Dependent Mannose Kinase
by: Wenlong Zhu, et al.
Published: (2019-03-01)

Panicle Morphology Mutant 1 (PMM1) determines the inflorescence architecture of rice by controlling brassinosteroid biosynthesis
by: Yan Li, et al.
Published: (2018-12-01)

Terminal Mannose Residues in Seminal Plasma Glycoproteins of Infertile Men Compared to Fertile Donors
by: Beata Olejnik, et al.
Published: (2015-07-01)

Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation
by: Jessica P. Lao, et al.
Published: (2019-02-01)

Defects in Galactose Metabolism and Glycoconjugate Biosynthesis in a UDP-Glucose Pyrophosphorylase-Deficient Cell Line Are Reversed by Adding Galactose to the Growth Medium
by: Christelle Durrant, et al.
Published: (2020-03-01)

NANS-CDG: Delineation of the Genetic, Biochemical, and Clinical Spectrum
by: Bibiche den Hollander, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_gja4mpmes5shlnv9uu8os0glrh